Patient and Physician Behavior
Our work in Patient and Physician Behavior
-
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves
Use of direct oral anticoagulants gradually increased since 2011, with a significant upward in trend after a stay-at-home order related to COVID-19.
Categorized in -
Don’t Make Surgery Another COVID Casualty
Investing in minimally invasive tools can free up valuable beds when pandemic surges threaten to overwhelm hospitals, argues Van Nuys and Lakdawalla in MedPage Today.
Categorized in -
Mental Associations with COVID-19 and How They Relate with Self-Reported Protective Behaviors
Adoption of protective behaviors for COVID-19 depends on what disease individuals associated with the novel coronavirus.
Categorized in -
Reassessing the Value of Minimally Invasive Technologies in the Era of COVID-19
Minimally invasive technologies are capacity-conserving technologies that could reduce burdens on healthcare providers and hospitals while also shielding patients from unnecessary in-hospital exposure to pathogens.
Categorized in -
Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
A new study from Schaeffer Center experts finds that immediately after Los Angeles’ safer-at-home declaration, emergency department utilization dropped by 37% compared to the same 9 weeks in the prior two years.
Categorized in -
Health Technology Assessment with Diminishing Returns to Health: The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Approach
Generalized Risk-Adjusted Cost-Effectiveness (GRACE) approach helps align HTA practice with realistic preferences for health and risk.
Categorized in -
How to Encourage Vaccine Adoption
How can public health leaders address vaccine hesitancy? Join the USC-Brookings Schaeffer Initiative for Health Policy and the USC Behavioral Science and Well-Being Policy Initiative for an expert discussion on vaccine adoption.
Categorized in -
Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
The researchers examine changes in health care use during the first 2 months of the COVID-19 pandemic in March and April of 2020 relative to March and April of 2019 and 2018, and to examine whether changes in use differ by patient’s zip code–level race/ethnicity or income.
Categorized in -
BMJ: What Current and Missing Data Can Teach Us About Medication Errors
The cost of medication errors worldwide exceeds $42 billion, or approximately 5%–6% of all hospitalizations. There are a number of cost-effective strategies that could be deployed to reduce the quantity of adverse drug events.
Categorized in -
Details Matter: Predicting When Nudging Clinicians Will Succeed or Fail
Subtle implementation details can greatly influence the effectiveness of behavioural nudges because of their inherent subjective and social nature
Categorized in